Q3 2020 Holdings
Filed 2020-11-16 | 46 holdings | $786.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma(ASND) | Sponsored ADR | 04351P101 | $277.8M | 1,800,000 | 35.3% |
| Argenx SE(ARGX) | Sponsored ADR | 04016X101 | $236.9M | 902,500 | 30.1% |
| Biomarin Pharmaceutical Inc(BMRN) | Common | 09061G101 | $133.1M | 1,750,000 | 16.9% |
| Adaptimmune Therapeutics PLC(ADAPY) | Sponsored ADR | 00653A107 | $87.8M | 11,000,000 | 11.2% |
| Altimmune Inc(ALT) | Common | 02155H200 | $26.4M | 2,000,000 | 3.4% |
| Black Diamond Therapeutics Inc(BDTX) | Common | 09203E105 | $18.2M | 602,500 | 2.3% |
| Immunomedics Inc(IMMU) | Common | 452907108 | $2.2M | 26,250,000 | 0.3% |
| Mirati Therapeutics Inc(MRTXEUR) | Common | 60468T105 | $721.2K | 4,343,000 | 0.1% |
| Horizon Therapeutics PLC | Common | G46188101 | $594.3K | 7,650,000 | 0.1% |
| Iovance Biotherapeutics Inc(IOVA) | Common | 462260100 | $313.9K | 9,536,039 | 0.0% |
| Myokardia Inc | Common | 62857M105 | $257.0K | 1,885,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | Common | 803607100 | $235.2K | 1,675,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | Common | 040047607 | $231.8K | 3,100,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | Common | 03152W109 | $153.2K | 10,850,000 | 0.0% |
| Acceleron Pharma Inc(XLRN) | Common | 00434H108 | $151.9K | 1,350,000 | 0.0% |
| Mersana Therapeutics Inc | Common | 59045L106 | $126.6K | 6,800,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | Common | 558868105 | $105.7K | 890,000 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | Common | 24344T101 | $93.4K | 1,820,000 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | Common | 48576U106 | $87.6K | 6,000,000 | 0.0% |
| Constellation Pharmaceuticals Inc(CNST) | Common | 210373106 | $86.6K | 4,275,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | Common | 00773U108 | $82.4K | 8,000,000 | 0.0% |
| Trillium Therapeutics Inc | Common | 89620X506 | $78.2K | 5,500,000 | 0.0% |
| Kura Oncology Inc(KURA) | Common | 50127T109 | $74.6K | 2,435,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | Common | 23257D103 | $74.6K | 10,300,000 | 0.0% |
| Uniqure NV(QURE) | Common | N90064101 | $64.5K | 1,750,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | Common | 69353Y103 | $57.6K | 1,850,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | Common | 75955J402 | $56.4K | 1,500,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | Common | 46583P102 | $40.9K | 7,250,000 | 0.0% |
| Athenex Inc(ATNXEUR) | Common | 04685N103 | $39.5K | 3,265,000 | 0.0% |
| Marinus Pharmaceuticals Inc | Common | 56854Q101 | $38.6K | 3,000,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | Common | 98420N105 | $31.0K | 2,800,000 | 0.0% |
| CUE Biopharma Inc(CUE) | Common | 22978P106 | $28.1K | 1,870,000 | 0.0% |
| Amarin Corp PLC | Sponsored ADR | 023111206 | $25.3K | 6,000,000 | 0.0% |
| Retrophin Inc | Common | 761299106 | $24.5K | 1,325,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | Common | 75943R102 | $21.3K | 500,000 | 0.0% |
| Avadel Pharmaceuticals PLC | Sponsored ADR | 05337M104 | $21.2K | 4,200,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | Common | 75382E109 | $18.5K | 575,000 | 0.0% |
| Zogenix Inc | Common | 98978L204 | $15.7K | 875,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | Common | 05370A108 | $15.3K | 545,000 | 0.0% |
| Therapeutics Acquisition Corp | Common | 88339T103 | $14.4K | 1,000,000 | 0.0% |
| Genocea Biosciences Inc(GNCAQ) | Common | 372427401 | $11.6K | 5,084,184 | 0.0% |
| Iteos Therapeutics Inc(5E7) | Common | 46565G104 | $11.3K | 460,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | Common | 31447P100 | $10.1K | 1,670,000 | 0.0% |
| Bctg Acquisition Corp | Common | 05492W103 | $8.7K | 800,000 | 0.0% |
| Alimera Sciences Inc | Common | 016259202 | $2.0K | 415,999 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | Common | 501575104 | $1.6K | 49,400 | 0.0% |